bendiocarb has been researched along with Liver Steatosis in 1 studies
bendiocarb: FICAM 80W contains 80% of the above chemical cpd as the active ingredient
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Petrovova, E | 1 |
| Purzyc, H | 1 |
| Mazensky, D | 1 |
| Luptakova, L | 1 |
| Torma, N | 1 |
| Sopoliga, I | 1 |
| Sedmera, D | 1 |
1 other study available for bendiocarb and Liver Steatosis
| Article | Year |
|---|---|
Morphometric alterations, steatosis, fibrosis and active caspase-3 detection in carbamate bendiocarb treated rabbit liver.
Topics: Animals; Apoptosis; Caspase 3; Cell Count; Chemical and Drug Induced Liver Injury; Fatty Liver; Fema | 2015 |